Literature DB >> 16648155

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.

M P Conte1, S Schippa, I Zamboni, M Penta, F Chiarini, L Seganti, J Osborn, P Falconieri, O Borrelli, S Cucchiara.   

Abstract

BACKGROUND: Clinical and experimental observations in animal models indicate that intestinal commensal bacteria are involved in the initiation and amplification of inflammatory bowel disease (IBD). No paediatric reports are available on intestinal endogenous microflora in IBD. AIMS: To investigate and characterise the predominant composition of the mucosa-associated intestinal microflora in colonoscopic biopsy specimens of paediatric patients with newly diagnosed IBD.
METHODS: Mucosa-associated bacteria were quantified and isolated from biopsy specimens of the ileum, caecum and rectum obtained at colonoscopy in 12 patients with Crohn's disease, 7 with ulcerative colitis, 6 with indeterminate colitis, 10 with lymphonodular hyperplasia of the distal ileum and in 7 controls. Isolation and characterisation were carried out by conventional culture techniques for aerobic and facultative-anaerobic microorganisms, and molecular analysis (16S rRNA-based amplification and real-time polymerase chain reaction assays) for the detection of anaerobic bacterial groups or species.
RESULTS: A higher number of mucosa-associated aerobic and facultative-anaerobic bacteria were found in biopsy specimens of children with IBD than in controls. An overall decrease in some bacterial species or groups belonging to the normal anaerobic intestinal flora was suggested by molecular approaches; in particular, occurrence of Bacteroides vulgatus was low in Crohn's disease, ulcerative colitis and indeterminate colitis specimens.
CONCLUSION: This is the first paediatric report investigating the intestinal mucosa-associated microflora in patients of the IBD spectrum. These results, although limited by the sample size, allow a better understanding of changes in mucosa-associated bacterial flora in these patients, showing either a predominance of some potentially harmful bacterial groups or a decrease in beneficial bacterial species. These data underline the central role of mucosa-adherent bacteria in IBD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648155      PMCID: PMC1856471          DOI: 10.1136/gut.2005.078824

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  43 in total

Review 1.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

2.  Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD.

Authors:  Patricia Lepage; Philippe Seksik; Malène Sutren; Marie-France de la Cochetière; Raymond Jian; Philippe Marteau; Joël Doré
Journal:  Inflamm Bowel Dis       Date:  2005-05       Impact factor: 5.325

3.  Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: an indication of enhanced immune response?

Authors:  Jorma Kokkonen; Tuomo J Karttunen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-01       Impact factor: 2.839

4.  The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.

Authors:  C Schultsz; F M Van Den Berg; F W Ten Kate; G N Tytgat; J Dankert
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

5.  Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells.

Authors:  J Boudeau; N Barnich; A Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

6.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

Review 7.  Adaptation of bacteria to the intestinal niche: probiotics and gut disorder.

Authors:  C Dunne
Journal:  Inflamm Bowel Dis       Date:  2001-05       Impact factor: 5.325

8.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation.

Authors:  M Hausmann; S Kiessling; S Mestermann; G Webb; T Spöttl; T Andus; J Schölmerich; H Herfarth; K Ray; W Falk; G Rogler
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

View more
  135 in total

Review 1.  Crohn disease: a current perspective on genetics, autophagy and immunity.

Authors:  Thaddeus S Stappenbeck; John D Rioux; Atsushi Mizoguchi; Tatsuya Saitoh; Alan Huett; Arlette Darfeuille-Michaud; Tom Wileman; Noboru Mizushima; Simon Carding; Shizuo Akira; Miles Parkes; Ramnik J Xavier
Journal:  Autophagy       Date:  2011-04-01       Impact factor: 16.016

2.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: induction and control of regulatory T cells in the gastrointestinal tract: consequences for local and peripheral immune responses.

Authors:  Y Belkaid; O Liesenfeld; R M Maizels
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 3.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

4.  Novel Burkholderiales 23S rRNA genes identified in ileal biopsy samples from children: preliminary evidence that a subtype is associated with perianal Crohn's disease.

Authors:  W H Sim; J Wagner; D J Cameron; A G Catto-Smith; R F Bishop; C D Kirkwood
Journal:  J Clin Microbiol       Date:  2010-03-17       Impact factor: 5.948

5.  Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India.

Authors:  Ravi Verma; Anil Kumar Verma; Vineet Ahuja; Jaishree Paul
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

6.  Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.

Authors:  Misagh Alipour; Deenaz Zaidi; Rosica Valcheva; Juan Jovel; Inés Martínez; Consolato Sergi; Jens Walter; Andrew L Mason; Gane Ka-Shu Wong; Levinus A Dieleman; Matthew W Carroll; Hien Q Huynh; Eytan Wine
Journal:  J Crohns Colitis       Date:  2015-12-09       Impact factor: 9.071

Review 7.  Microbial control of regulatory and effector T cell responses in the gut.

Authors:  Timothy Hand; Yasmine Belkaid
Journal:  Curr Opin Immunol       Date:  2010-02-18       Impact factor: 7.486

8.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease.

Authors:  Roman Kotlowski; Charles N Bernstein; Shadi Sepehri; Denis O Krause
Journal:  Gut       Date:  2006-10-06       Impact factor: 23.059

Review 9.  Diagnosis and management of inflammatory bowel disease in children.

Authors:  Stephanie B Oliveira; Iona M Monteiro
Journal:  BMJ       Date:  2017-05-31

10.  Paneth cell defects in Crohn's disease patients promote dysbiosis.

Authors:  Ta-Chiang Liu; Bhaskar Gurram; Megan T Baldridge; Richard Head; Vy Lam; Chengwei Luo; Yumei Cao; Pippa Simpson; Michael Hayward; Mary L Holtz; Pavlos Bousounis; Joshua Noe; Diana Lerner; Jose Cabrera; Vincent Biank; Michael Stephens; Curtis Huttenhower; Dermot Pb McGovern; Ramnik J Xavier; Thaddeus S Stappenbeck; Nita H Salzman
Journal:  JCI Insight       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.